InvestorsHub Logo
Followers 51
Posts 3938
Boards Moderated 0
Alias Born 03/20/2014

Re: None

Wednesday, 10/16/2019 6:55:10 PM

Wednesday, October 16, 2019 6:55:10 PM

Post# of 459928
From my notes, not guaranteeing accuracy.

At the Cowen presentation March 12th he said over 50% enrollment for PDD.

He said there would be an announcement of when the enrollment was completed.

That could be the same day they announce top line data and still be accurate. imo

At the Wrainwright in April he said;

The first patient volunteered to go into the extension which is offered. Extension study consists of an open label 12 weeks continuation to stay on study drug and we expect this extension study to be extended further as we’ve already done it in our previous clinical studies. So we expect that not to be time limited, the extension study.

At the 2nd Qtr Financial and Clinical Update he said PDD has achieved 70% of the total enrollment target to date. That was May 8th.

I think the trial might be done and things could be heating up in Australia. The Rett could be a misdirection. I wouldn't put it past him.

This is just a befuddled confused old man's opinion and should be taken with many grains of salt.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News